107 related articles for article (PubMed ID: 11192941)
1. Thrombolysis by thienopyridines and their congeners.
Gryglewski RJ; Dupin JP; Uracz W; Swiês J; Madej J; Hou G; Gravier D; Casadebaig F
J Physiol Pharmacol; 2000 Dec; 51(4 Pt 1):683-93. PubMed ID: 11192941
[TBL] [Abstract][Full Text] [Related]
2. Synthesis and thrombolytic activity of new thienopyrimidinone derivatives.
Dupin JP; Gryglewski RJ; Gravier D; Hou G; Casadebaig F; Swies J; Chlopicki S
J Physiol Pharmacol; 2002 Dec; 53(4 Pt 1):625-34. PubMed ID: 12512697
[TBL] [Abstract][Full Text] [Related]
3. Effects of clopidogrel and ticlopidine on experimental diabetic ischemic retinopathy in rats.
De La Cruz P; Arrebola M; González-Correa A; Martinez-Cerdán E; Moreno A; de la Cuesta FS
Naunyn Schmiedebergs Arch Pharmacol; 2003 Feb; 367(2):204-10. PubMed ID: 12595963
[TBL] [Abstract][Full Text] [Related]
4. Thienopyridines: effects on cultured endothelial cells.
Ziemianin B; Olszanecki R; Uracz W; Marcinkiewicz E; Gryglewski RJ
J Physiol Pharmacol; 1999 Dec; 50(4):597-604. PubMed ID: 10639010
[TBL] [Abstract][Full Text] [Related]
5. Thrombolytic activity of beta-adrenolytic drug, sotalol.
Korbut R; Swies J; Marcinkiewicz E; Gryglewski RJ
J Physiol Pharmacol; 1998 Mar; 49(1):51-60. PubMed ID: 9594410
[TBL] [Abstract][Full Text] [Related]
6. Clopidogrel versus prasugrel in rabbits. Effects on thrombosis, haemostasis, platelet function and response variability.
Wong PC; Crain EJ; Watson CA; Hua J; Schumacher WA; Rehfuss R
Thromb Haemost; 2009 Jan; 101(1):108-15. PubMed ID: 19132196
[TBL] [Abstract][Full Text] [Related]
7. [Synthesis of thienopyridine derivatives and its anti-platelet activity in vivo].
Zhou YS; Wang PB; Liu Y; Chen JF; Yue N; Liu DK
Yao Xue Xue Bao; 2011 Jan; 46(1):70-4. PubMed ID: 21465811
[TBL] [Abstract][Full Text] [Related]
8. Potentiating effect of clopidogrel and SR 46349, a novel 5-HT2 antagonist, on streptokinase-induced thrombolysis in the rabbit.
Herbert JM; Bernat A; Sainte-Marie M; Dol F; Rinaldi M
Thromb Haemost; 1993 Mar; 69(3):268-71. PubMed ID: 8470050
[TBL] [Abstract][Full Text] [Related]
9. Endothelial action of thienopyridines and thienopyrimidinones in the isolated guinea pig heart.
Jakubowski A; Chlopicki S; Olszanecki R; Jawien J; Lomnicka M; Dupin JP; Gryglewski RJ
Prostaglandins Leukot Essent Fatty Acids; 2005 Feb; 72(2):139-45. PubMed ID: 15626597
[TBL] [Abstract][Full Text] [Related]
10. Bioequivalence and tolerability of two clopidogrel salt preparations, besylate and bisulfate: a randomized, open-label, crossover study in healthy Korean male subjects.
Kim SD; Kang W; Lee HW; Park DJ; Ahn JH; Kim MJ; Kim EY; Kim SW; Nam HS; Na HJ; Yoon YR
Clin Ther; 2009 Apr; 31(4):793-803. PubMed ID: 19446152
[TBL] [Abstract][Full Text] [Related]
11. Thrombolytic action of ticlopidine: possible mechanisms.
Gryglewski RJ; Korbut R; Swies J; Kostka Trabka E; Bieroń K; Robak J
Eur J Pharmacol; 1996 Jul; 308(1):61-7. PubMed ID: 8836633
[TBL] [Abstract][Full Text] [Related]
12. Protein disulphide isomerase-mediated LA419- NO release provides additional antithrombotic effects to the blockade of the ADP receptor.
Vilahur G; Pena E; Padró T; Badimon L
Thromb Haemost; 2007 Apr; 97(4):650-7. PubMed ID: 17393029
[TBL] [Abstract][Full Text] [Related]
13. Combined anti-platelet therapy with aspirin and clopidogrel: risk factor for thrombolysis-related intracerebral hemorrhage in acute ischemic stroke?
Hermann A; Dzialowski I; Koch R; Gahn G
J Neurol Sci; 2009 Sep; 284(1-2):155-7. PubMed ID: 19473668
[TBL] [Abstract][Full Text] [Related]
14. Short-term inhibition of ADP-induced platelet aggregation by clopidogrel ameliorates radiation-induced toxicity in rat small intestine.
Wang J; Albertson CM; Zheng H; Fink LM; Herbert JM; Hauer-Jensen M
Thromb Haemost; 2002 Jan; 87(1):122-8. PubMed ID: 11848440
[TBL] [Abstract][Full Text] [Related]
15. N-methylnicotinamide inhibits arterial thrombosis in hypertensive rats.
Mogielnicki A; Kramkowski K; Pietrzak L; Buczko W
J Physiol Pharmacol; 2007 Sep; 58(3):515-27. PubMed ID: 17928647
[TBL] [Abstract][Full Text] [Related]
16. Overcoming clopidogrel resistance: discovery of vicagrel as a highly potent and orally bioavailable antiplatelet agent.
Shan J; Zhang B; Zhu Y; Jiao B; Zheng W; Qi X; Gong Y; Yuan F; Lv F; Sun H
J Med Chem; 2012 Apr; 55(7):3342-52. PubMed ID: 22428882
[TBL] [Abstract][Full Text] [Related]
17. P2Y receptor antagonists in thrombosis.
Boeynaems JM; van Giezen H; Savi P; Herbert JM
Curr Opin Investig Drugs; 2005 Mar; 6(3):275-82. PubMed ID: 15816504
[TBL] [Abstract][Full Text] [Related]
18. Effects of clopidogrel on survival of rat skin flaps.
Ersoy A; Sevin K; Sevin A; Serel S
J Plast Reconstr Aesthet Surg; 2007; 60(8):861-3. PubMed ID: 17418655
[TBL] [Abstract][Full Text] [Related]
19. Developments in the synthesis of the antiplatelet and antithrombotic drug (S)-clopidogrel.
Saeed A; Shahzad D; Faisal M; Larik FA; El-Seedi HR; Channar PA
Chirality; 2017 Nov; 29(11):684-707. PubMed ID: 28875522
[TBL] [Abstract][Full Text] [Related]
20. The use of the VerifyNow P2Y12 point-of-care device to monitor platelet function across a range of P2Y12 inhibition levels following prasugrel and clopidogrel administration.
Jakubowski JA; Payne CD; Li YG; Brandt JT; Small DS; Farid NA; Salazar DE; Winters KJ
Thromb Haemost; 2008 Feb; 99(2):409-15. PubMed ID: 18278193
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
